These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27306834)

  • 1. Naïve CD8(+) T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment.
    Nguyen HH; Kim T; Song SY; Park S; Cho HH; Jung SH; Ahn JS; Kim HJ; Lee JJ; Kim HO; Cho JH; Yang DH
    Sci Rep; 2016 Jun; 6():28208. PubMed ID: 27306834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition.
    Danahy DB; Berton RR; Badovinac VP
    J Immunol; 2020 Mar; 204(6):1431-1435. PubMed ID: 32051220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells.
    Xie Y; Xie F; Zhang L; Zhou X; Huang J; Wang F; Jin J; Zhang L; Zeng L; Zhou F
    Adv Sci (Weinh); 2021 Nov; 8(22):e2101672. PubMed ID: 34658167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling.
    Nguyen KB; Spranger S
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31816057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modal Ca
    An J; Guo R; Liu M; Hu H; Zhang H
    J Control Release; 2024 Aug; 372():715-727. PubMed ID: 38955253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resident memory T cells and cancer.
    Gavil NV; Cheng K; Masopust D
    Immunity; 2024 Aug; 57(8):1734-1751. PubMed ID: 39142275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.
    Germann M; Zangger N; Sauvain MO; Sempoux C; Bowler AD; Wirapati P; Kandalaft LE; Delorenzi M; Tejpar S; Coukos G; Radtke F
    EMBO Mol Med; 2020 Jan; 12(1):e10681. PubMed ID: 31793740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).
    Luan J; Liu Y; Cao M; Guo X; Guo N
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38904200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reactive, innate-like T cells enhance cytotoxicity and immunosurveillance.
    Barton BE; Chau CH; Figg WD
    Trends Cancer; 2022 Aug; 8(8):629-631. PubMed ID: 35672242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Not Forget the Granulocytic Compartment's Role in T cell-Mediated Antitumor Immunity.
    Gaipl US
    Cancer Immunol Res; 2024 Jul; 12(7):798-799. PubMed ID: 38952273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell metabolic profiling of human cytotoxic T cells.
    Hartmann FJ; Mrdjen D; McCaffrey E; Glass DR; Greenwald NF; Bharadwaj A; Khair Z; Verberk SGS; Baranski A; Baskar R; Graf W; Van Valen D; Van den Bossche J; Angelo M; Bendall SC
    Nat Biotechnol; 2021 Feb; 39(2):186-197. PubMed ID: 32868913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Cycle Entry Control in Naïve and Memory CD8
    Lewis DA; Ly T
    Front Cell Dev Biol; 2021; 9():727441. PubMed ID: 34692683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZBTB46 coordinates angiogenesis and immunity to control tumor outcome.
    Kabir AU; Zeng C; Subramanian M; Wu J; Kim M; Krchma K; Wang X; Halabi CM; Pan H; Wickline SA; Fremont DH; Artyomov MN; Choi K
    Nat Immunol; 2024 Sep; 25(9):1546-1554. PubMed ID: 39134750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study.
    Cortes-Selva D; Perova T; Skerget S; Vishwamitra D; Stein S; Boominathan R; Lau O; Calara-Nielsen K; Davis C; Patel J; Banerjee A; Stephenson T; Uhlar C; Kobos R; Goldberg J; Pei L; Trancucci D; Girgis S; Wang Lin SX; Wu LS; Moreau P; Usmani SZ; Bahlis NJ; van de Donk NWCJ; Verona RI
    Blood; 2024 Aug; 144(6):615-628. PubMed ID: 38657201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides.
    Huang D; Zhu X; Ye S; Zhang J; Liao J; Zhang N; Zeng X; Wang J; Yang B; Zhang Y; Lao L; Chen J; Xin M; Nie Y; Saw PE; Su S; Song E
    Nature; 2024 Jan; 625(7995):593-602. PubMed ID: 38093017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patients.
    Chiu YJ; Ni CE; Huang YH
    Cancer Med; 2023 Jul; 12(14):15736-15760. PubMed ID: 37366298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 limits differentiation and plasticity of Tc17 cells.
    Arra A; Lingel H; Pierau M; Brunner-Weinzierl MC
    Front Immunol; 2023; 14():1104730. PubMed ID: 37205114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors.
    Liguori L; Polcaro G; Nigro A; Conti V; Sellitto C; Perri F; Ottaiano A; Cascella M; Zeppa P; Caputo A; Pepe S; Sabbatino F
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SECANT: a biology-guided semi-supervised method for clustering, classification, and annotation of single-cell multi-omics.
    Wang X; Xu Z; Hu H; Zhou X; Zhang Y; Lafyatis R; Chen K; Huang H; Ding Y; Duerr RH; Chen W
    PNAS Nexus; 2022 Sep; 1(4):pgac165. PubMed ID: 36157595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy.
    Shin HG; Yang HR; Yoon A; Lee S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.